Long-term control of prostate cancer with radiation. Past, present, and future (Q40921888)

24 September 2017

1 reference

title

Long-term control of prostate cancer with radiation. Past, present, and future (English)

1 reference

24 September 2017

Hanks GE

1

1 reference

24 September 2017

publication date

1 November 1996

1 reference

Urologic Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

23

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

605-616

1 reference

Results of conservative management of clinically localized prostate cancer.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy: the need for improved systemic and locoregional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Early Prostate Cancer: The National Results of Radiation Treatment from the Patterns of Care and Radiation Therapy Oncology Group Studies With Prospects for Improvement with Conformal Radiation and Adjuvant Androgen Deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Radical surgery versus radiotherapy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Prognostic significance of nodal involvement in locally advanced (stage C) carcinoma of prostate--RTOG experience

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Definitive therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970339-6

7 January 2021

10.1016/S0094-0143(05)70339-6

Identifiers

DOI

1 reference

24 September 2017

1 reference